Company intelligence / Profile preview

JN Bidco

Puerto Rico, United States

Ownership: Private
Development stage: Other

Overview

JN Bidco LLC is a private acquisition vehicle that acquired substantially all assets of Impel Pharmaceuticals through a Section 363 bankruptcy sale in February 2024, including the Trudhesa migraine franchise and POD nasal delivery technology.[3][5][6][8][9][10][13]

Industry: Investors

Partnerships

Impel Pharmaceuticals (asset purchase of Trudhesa and POD nasal delivery assets via bankruptcy sale)[3][5][6][8][9][10][13]

Beyond the preview

Go deeper on JN Bidco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JN Bidco.

Explore the full profile